Tuberculosis: Causes, Effects, Symptoms and Prevention Measures
Bacterial infections range from mild skin infections to more complicated diseases such as tuberculosis and bubonic plague. Advanced antibiotics, vaccines, and improved sanitation have over the years caused significant reductions in the mortality rates resulting from bacterial infections. Cases of resurgence have, however, been reported in some instances as a result of the evolution of strains that are resistant to antibiotics. Tuberculosis comes about when disease-causing bacteria induce sensitivity into the host's antigenic system (Clark 181). This text examines the costs imposed by TB on an individual and the economy and how the incidence of TB can be controlled. It hypothesizes that the control of TB is not a one-nation affair; in order to effectively combat TB within its borders, a nation must work hand in hand with other nations.
TB was once thought to be headed for extinction. Recent statistics, however, depict that this is not about to happen anytime soon. The disease has, in recent years, been affecting more people, especially in large, densely-populated town centers around the globe (Clark 181). Deadlier forms of the disease "have arisen in immunocompromised individuals, such as those with AIDS, or patients being treated with immunosuppressive drugs in connection with organ transplantation," a trend that has seen TB go up the ranks to become one of the most dreaded diseases, and a major cause of death in the world today (Clark 181).
TB in humans exists either in the latent or in the active form. In the latent form, the TB-causing bacterium is inhaled but the immune system is able to inhibit its growth, such that the host is in no position to spread the same to others and shows no symptoms, but still runs the risk of developing the active form of the disease if diagnosis and treatment are not advanced (Queensland Health). However, it is the active form of TB, which is deadlier and has more disastrous effects on both self and others that forms the basis of the text. In this form, the immune system is not strong enough to stop bacterial activity; the bacteria get active, and multiply, weakening the host's body and increasing its ability to spread the bacteria to others (CDC).
The Mycobacterium Tuberculosis bacterium is responsible for causing TB in humans, whereas the M. avium and the M.bovis are more prevalent in animals (Queensland Health). M. Tuberculosis is a slow-growing thin, large bacillus, with an almost impermeable cell wall made of the wax-like mycolic acid (CDC). Although the lungs are the most common target, the tuberculosis bacterium can infect almost any part of the human body including the brain, spine, and the kidney.
TB is an air-borne disease spread when the causative bacterium, released into the air when a person infected with active TB sings, coughs or sneezes, is breathed in by an uninfected person (CDC). On reaching the lungs, the bacterium faces resistance from the alveolar macrophages (the pathogen-destroying cells of the lungs) which form mycobacterium-containing lesions, at which point the TB disease takes the latent form (CDC). Most of the TB infections stop at this point and do not proceed to the active stage. However, if the host's immune system is unable to inhibit the growth of the bacteria, the disease...
The bacteria, for instance, require oxygen produced by the breakdown of fatty acids for growth - which is the reason why the lungs, the body's fundamental source of oxygen, are commonly infected. However, if the host's source is not providing enough of this, the bacteria adapt by using nitrate rather than oxygen in their ATP production (CDC).
Pulmonary TB was first reported between 688 and 626 BC as a disease with symptoms such as frequent coughs, thick bloody sputum, flute-like breathing, chills and sweats, diarrhea and heart disturbance (Kaye and Frieden 52). Prior to this, signs of M. bovis bacterial infection had been observed in cows. It is widely believed that M. tuberculosis developed from the M. bovis strain and adapted itself to the human system when cattle farming began between 8000 and 4000 AD (Kaye and Frieden 53). Science, in the seventeenth and eighteenth centuries, demonstrated that there were observed physical changes in the lungs of an infected person, but it was not until the end of the 19th century that scientist Robert Koch brought TB to light and proved that it was caused by the M. tuberculosis bacterium which was easily spread through the air (Kaye and Frieden 53). The incidences of death resulting from the same were not as high then, mainly because immunity-weakening conditions such as diabetes, AIDS, and organ transplant complications had not come to light.
Statistics show that a "third of the world's population is infected with TB" (CDC). Approximately 9 million new infections and more than 1.3 million TB-related deaths were reported in 2012 alone, most of which were HIV cases. Today, TB is the world's leading killer of people infected with AIDS (CDC). The U.S., in 2012, reported 9,945 cases of active TB, representing a rate of 4 per every 100,000 persons (CDC). This is worrying, considering that it takes just one droplet of infected sputum to infect an individual of sound health with TB (Queensland Health).
Prevention and Treatment
The treatment of active TB takes the form of a series of antibiotics, some of which are meant to kill, and others to prevent the bacteria from becoming drug-resistant (Kaye and Frieden 53). The most common of these antibiotics are pyrazinamide, ethambutol, rifampin, and isoniazid (CDC). Most patients feel better within the first month of treatment and are then tempted to skip doses or quit medication. This trend explains why cases of drug-resistant TB are on the rise (Kaye and Frieden 53). Directly Observed Therapy (DOT) is an effective way of ensuring that a TB patient follows the physician's prescription to the latter. Moreover, surgery can be used to treat TB, especially if medication proves ineffective (CDC). The two procedures of corrective surgery commonly used include; i) pneumothorax -- introducing air into the chest so as to make the lungs collapse, and ii) thoracoplasty - the removal of diseased ribs or lungs (CDC).
Different preventive measures have been taken by different countries to reduce the chances of healthy individuals contracting TB. In the U.S., such measures include isolation, air filtration and the enactment of legislation requiring prisons, hospitals, and other social interaction zones to comply with tight ventilation standards (CDC). Additionally, the Bacillus Camille Guerin (BCG) vaccine has been adopted to safeguard against the spread of some types of TB (CDC). The vaccine works by strengthening the immune systems of first-time TB patients and thus lessening the likelihood of them developing any serious TB-related complications - it has been found to be more effective when administered to infants, than to adults (CDC).
Political, Economic, and Social Issues
TB imposes serious economic and social problems on an economy; 80% of those affected are aged between 15 and 49, a bracket that represents the highest economic potential of a nation (Kaye and Frieden 59). Moreover, a large proportion of this does not get diagnosed in time and, due to this, stands to lose not less than a year of work to treatment (Kaye and Frieden 59). A TB pandemic between 1992 and 1996 in New York…
CDC. "Tuberculosis." Centers for Disease Control and Prevention, 2012. Web. 25 March 2014 http://www.cdc.gov/tb/topic/default.htm
Clark, William. The New Healers: the Promises and Problems of Molecular Medicine in the Twenty-First Century. New York: Oxford University, 1997. Print.
Kaye, Katherine, and Frieden Thomas. "Tuberculosis Control: the Relevance of Classic Principles in an Era of Acquired Immunodeficiency Syndrome and Multidrug Resistance." Epidemiological Reviews 18.1 (1996): 52-63. Print.
Queensland Health. "Topic: Tuberculosis TB." Queensland Government, 2013. Web. 25 March 2014 http://access.health.qld.gov.au/hid/LungandAirwayHealth/InfectionsandParasites/tuberculosisTb_fs.asp
Tuberculosis Communicable disease: Tuberculosis Tuberculosis is a widespread, lethal, and infectious/transmittable disease caused by Mycobacterium tuberculosis. This bacterial infection usually begins in the form of innumerable strains of mycobacteria. In the past, tuberculosis was also termed as Phthisis or Phthisis pulmonalis. Its short form is known worldwide to be TB, or MTB. Stereotypically, tuberculosis is a lung infection that attacks the lungs; however, it can as well affect the other parts of
Tuberculosis The Emergence and Re-emergence of Tuberculosis: Prevalence of Multi-Drug-Resistant Tuberculosis in the 21st Century In the 2003 lung disease statistics, tuberculosis is considered the "foremost cause of death from a single infectious disease," wherein TB is prevalent among developing countries, causing 99% of deaths (ALA, 2004). Indeed, American Lung Association (2004) considers tuberculosis as the an "ancient scourge," gaining prevalence in the 19th century and resurging once again in the 21st
Tuberculosis in Newham Borough of London The Urban Health Profile It is true that as long as there have been human beings on planet earth there has been a certain amount of struggle against disease and creatures that carry disease along with bacteria and viruses. These are the types of struggles and successes which have determined whether or not civilizations would triumph or be defeated, and these are the struggles which will
Others are more reckless and assume that they simply will not get sick. No matter who they are or where they come from, though, anyone can contract TB if they get around someone who is infected, so people must put social, cultural, and other opinions aside in order to protect themselves and others around them from potentially deadly diseases like TB (Lawlor, 2007). Conclusion It is very easy to see that
From the lung apices to the hemi-diaphragms, 1.5-mm thick sections were taken at 10-mm intervals. The images were prospectively reconstructed with the use of a high-resolution bone algorithm in diagnosing the lung lesions. The HRCT results were then compared with the results of clinical and para-clinical work-up on the patients. The analysis and comparison of rank values were performed using the chi-square P-values less than 0.05, and the sensitivity,
5 per 100,000 in 1986. In 1994, the number of TB cases among residents of correctional facilities for 59 reporting areas had reached 24,361 (4.6% of the total reporting correctional population) (Braithwaite et al.). The incidence rate was 139.3 per 100,000 by 1993 and the unadjusted case rates for prison populations in many areas are significantly higher than the rates for the general population (Braithwaite et al.). According to these